Kevin Robinson | Editor

Articles and archive:

Active Nutrition | Analysis | Cell & Gene Therapy | Containment | Contamination Control | Digital | Distribution | Dosage Forms | Drug Delivery | Finance | Food | Hi Tech Manufacturing | Ingredients | Logistics | Manufacturing | Marketing | Media | Medical Devices | Packaging | Pharma 5.0 | Pharmaceutical | Regulatory | Research & Development | Sustainability

Dr Kevin Robinson is a former molecular biologist turned writer, publishing executive and editor with extensive media experience in the life science, pharmaceutical and nutraceutical sectors

Kevin Robinson

Related content

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Taking biologic therapies out of the clinic

Taking biologic therapies out of the clinic

How larger autoinjectors are changing drug delivery device testing
Finance
Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub

Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub

Purpose-built facility will support Phase II and III trials and broaden participation across Glasgow and the west of Scotland
Pharma 5.0
Clinisys unveils governed AI roadmap for connected laboratories

Clinisys unveils governed AI roadmap for connected laboratories

Connected Laboratory Intelligence links trusted data, analytics, agents and automation to help laboratories move from insight to action
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part II)

Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part II)

How a centralised qualification matrix reconciles vendor documentation, integrates risk-based verification and connects commissioning findings with deviation, CAPA and audit-ready evidence
Research & Development
University of Sussex research reveals how leukaemia cells evade treatment

University of Sussex research reveals how leukaemia cells evade treatment

Computer modelling and patient samples reveal alternative survival signalling in CLL, potentially enabling earlier treatment choices and more personalised care
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part I)

Beyond FAT and SAT: a practical framework to qualify multivendor pharmaceutical manufacturing lines (part I)

Documentation Specialist Snehal Godse explains why unit-level FAT and SAT leave critical multivendor interfaces unverified and proposes a risk-based framework to qualify product transfers, control signals, interlocks, sensors and shared utilities
You need to be a subscriber to read this article.
Click here to find out more.
Pharma 5.0
AI agents target drug safety, protein discovery and secure health data analysis

AI agents target drug safety, protein discovery and secure health data analysis

Three companies serving the life sciences sector have unveiled new artificial intelligence tools spanning safety reporting, protein engineering and secure health data analysis
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Biology + chemistry: changing the way drug developers think about innovation and therapeutic design (part I)

Biology + chemistry: changing the way drug developers think about innovation and therapeutic design (part I)

Drug development's next frontier isn't new molecules; it's unlocking existing therapies by uniting biology and chemistry in a design space where linkers, tracers and modifications drive safer and more precise therapeutic innovation
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Japanese researchers report advances in liver disease treatment and cancer screening

Japanese researchers report advances in liver disease treatment and cancer screening

Two research teams in Japan have published findings that could open new avenues in metabolic disease treatment and non-invasive cancer screening
You need to be a subscriber to read this article.
Click here to find out more.
Cell & Gene Therapy
When the raw material is human: why cell therapy manufacturing breaks the traditional GMP model

When the raw material is human: why cell therapy manufacturing breaks the traditional GMP model

Cell therapy manufacturing challenges the core assumptions of pharmaceutical production; as such, the operational question for manufacturers is whether simply layering existing regulatory frameworks together is enough
Regulatory
From recipes to assays: the historical development of analysis in the British Pharmacopoeia

From recipes to assays: the historical development of analysis in the British Pharmacopoeia

This article traces how the British Pharmacopoeia moved from a compounding manual towards a system of analytical standards. It argues that the change was gradual rather than sudden, with 1914 and 1932 marking especially important stages in the move from preparation instructions to identity, purity and assay requirements
Manufacturing
From fermentation to high containment: Indena’s integrated European platform for HPAPIs and ADC payloads

From fermentation to high containment: Indena’s integrated European platform for HPAPIs and ADC payloads

Indena combines fermentation, botanical sourcing, high-containment processing and GMP scale-up expertise to help sponsors reduce hand‑offs in complex HPAPI and ADC payload supply chains